Ovensa Inc. works with pharmaceutical companies to enhance the stability and delivery of their RNA therapeutics, antibodies or peptides for vaccine and CNS applications. The company leverages its proprietary Trimethyl Chitosan (TRIOZAN™) and ligand targeting platforms to overcome drug delivery challenges such as crossing the mucosal and blood-brain barriers, cell targeting, payload internalization and endosomal escape.

Ovensa Inc. Logo



Event details

Date: June 13 - 16, 2022

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


26 in total